100 mg
KLOW
Blend of GHK-Cu, BPC-157, TB-500 and KPV. Studies on the individual components do not evaluate the blend.
For research use only
BPC-157
Synthetic peptide studied mainly in preclinical models of tissue repair, intestinal wound healing and inflammatory responses.
- Pay by card (Stripe) or Zelle
- Ships within the U.S. with tracking
- Questions? Call or email us
Benefits under study
Preclinical research in animals and cells.
- Tissue repair
- Intestinal wound healing
- Modulation of inflammation
Research overview
BPC-157 is a synthetic pentadecapeptide (15 amino acids) based on a sequence of a protein found in gastric juice. It is one of the most frequently studied peptides in preclinical models.
Preclinical research covers tissue-repair signaling, angiogenesis, gastrointestinal integrity and musculoskeletal recovery models, including fistula healing and experimental periodontitis in rats. Human clinical data remain limited.
Supplied as a 20 mg vial for laboratory research.
Scientific references
Pentadecapeptide BPC 157 is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system
J Pharmacol Sci, 2008 · PMID 18818478
View on PubMedAntiinflammatory effect of BPC 157 on experimental periodontitis in rats
J Physiol Pharmacol, 2009 · PMID 20388954
View on PubMed
You may also need
10 mg · 20 mg · 30 mg · 50 mg
Retatrutide
Investigational peptide targeting GIP, GLP-1 and glucagon receptors. Studied in clinical trials on body weight and glycemic control.
10 mg · 20 mg
Tesamorelin
GHRH analog studied in GH/IGF-1 signaling and visceral fat, including trials in people with HIV and altered fat distribution.